ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease. Read more in the #EHJ at doi.org/10.1093/eurhea…. #ApoB #Lipoproteins #CholesterolManagement @ESCardio European Society of Cardiology Journals

Semaglutide: more than weight loss? Our new meta-analysis in EJPC Editor-in-Chief (~49,000 pts) shows a 17% reduction in new-onset AFib. Great collaboration! Link: doi.org/10.1093/eurjpc… Arturo Cesaro AntonioAbbate

📌 Metanalysis 👉 Semaglutide -compared to placebo or active comparator- signif. ⬇️ the rate of new-onset AF #afib #Metanalysis #EPeeps #CardioTwitter #MedTwitter #diabetes #Obesity #diet Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Giuseppe Galati Jag Singh Alfonso Valle Diego Segura-Rodríguez Prof Dhiraj Gupta

📌 Acute coronary syndromes: mechanisms, challenges, & new opportunities Don’t miss it, share and ❤️ #ACS #Review European Society of Cardiology Journals

#mdpijcm 📝Happy to share new #review Long-Term Antithrombotic Therapy in Patients with #AtrialFibrillation and #PercutaneousCoronaryIntervention 🔗mdpi.com/3328636 by Antonio Capolongo et al. Felice Gragnano Vincenzo Acerbo SABOURETCardiologist Arturo Cesaro Paolo Calabro'

Guidelines recommend using imaging in complex #PCI . New meta-analysis of RCTs supports this and allows estimate the potential benefit of #IVUS or #OCT: NUMBER NEEDED TO TREAT is 11 pts to prevent one TVF in #LM PCI and of 27 in #bifurcation PCI.  openheart.bmj.com/content/12/1/e…

🫀 Lp(a): A major risk factor hiding in plain sight More than 1.4 billion people worldwide are living with elevated lipoprotein(a) – an inherited, independent cardiovascular risk factor strongly linked to heart attacks, strokes, aortic stenosis, and premature cardiovascular

🚀 New in European Society of Cardiology Journals our “AI in cardiovascular pharmacotherapy—applications & perspectives.” Link doi.org/10.1093/eurhea… 💊 AI will revolutionize cardiology, but what is the state of the art in CV pharmacotherapy? Is it ready for prime time? Let’s dive in ⬇️🧵 1️⃣/12

📍 This review summarizes the latest evidence on #cangrelor and discusses future directions for its application in clinical practice 📝 👉 tandfonline.com/doi/full/10.10… Paolo Calabro' Vincenzo De Sio Mattia Galli SABOURETCardiologist Giuseppe Gargiulo Marco Valgimigli Arturo Cesaro #CardioEd #CardioTwitter

#pubmed21 for 2025 thanks the group of Italian rising stars. What about #VitaminD and #CVR #Cardiotwitter ? Soon on ⁦Reviews in Cardiovascular Medicine⁩ ☀️

A personalized DAPT was superior to standard DAPT after PCI.📌Here are the slides presented at: #ESCCongress Mamas A. Mamas MIЯVΛƬ #IC ༄ ｡° Robert W. Yeh David J. Cohen, MD, MSc C. Michael Gibson MD Sripal Bangalore Francesco Costa Ash Paul د . احمد سمان Hany Ragy SABOURETCardiologist John Mandrola, MD Giovanni Esposito JACC Journals

📢 Fresh evidence! A new meta-analysis confirms the cardiovascular efficacy and safety of GLP-1 receptor agonists. An exceptional class of drugs with a growing role in cardiometabolic care. 💉❤️‍🩹 #GLP1RA #CardioDiabetes #CVOTs